Distinguished in Generalized Tonic-Clonic Seizure

Patrick L. Kwan

553 St Kilda Road, 
Melbourne, VIC, AU 
Distinguished in Generalized Tonic-Clonic Seizure
553 St Kilda Road, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Patrick Kwan practices in Melbourne, Australia. Mr. Kwan is rated as a Distinguished expert by MediFind in the treatment of Generalized Tonic-Clonic Seizure. His top areas of expertise are Epilepsy, Absence Seizure, Seizures, Generalized Tonic-Clonic Seizure, and Thrombectomy.

His clinical research consists of co-authoring 352 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 93 articles and participated in 2 clinical trials in the study of Generalized Tonic-Clonic Seizure.

Gender
Male

Locations

553 St Kilda Road, Melbourne, VIC 3004, Australia
Other Locations
Grattan Street, Parkville, VIC, Australia
99 Commercial Road, Melbourne, VIC 3004, Australia
792 Elizabeth Street, Melbourne, VIC 3000, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
Enrollment Status: Completed
Publish Date: November 22, 2024
Intervention Type: Device
Evaluation of Safety and Efficacy of BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures
Evaluation of Safety and Efficacy of BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures
Enrollment Status: Active_not_recruiting
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: BIS-001ER
Study Phase: Phase 1/Phase 2
A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome
A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome
Enrollment Status: Completed
Publish Date: January 27, 2022
Intervention Type: Drug
Study Drug: ANAVEX2-73
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

351 Total Publications

Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.
Journal: Neurology
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kwan's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile